Dianthus Therapeutics DNTH
NASDAQ DNTH
$87.16 -0.67 (-0.76%)
At close: Sep 29, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Common Equity (2017 - 2025)

Updated

Dianthus Therapeutics (DNTH) recorded Common Equity of $493.4 million in Q4 2025, up 40.0% from $352.48 million a year earlier but down 9.7% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Common Equity (2017 - 2025) Analysis & Trends

Starting with Q4 2017, Dianthus Therapeutics' Common Equity history includes 33 quarters.

  • Annual Common Equity has a five-year compound annual growth rate of 27.9% (FY2020 to FY2025).
  • Across earlier years, Common Equity came in at $352.48 million in FY2024 (+108.7%), $168.87 million in FY2023, -$44.37 million in FY2022 and -$17.25 million in FY2021.
  • Quarterly Common Equity has ranged from -$61.46 million in Q2 2023 to $546.45 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Common Equity rose in four of the last six quarters, with growth averaging 45.4%.
  • Peak year-over-year performance for Common Equity in the last five years was growth of 108.7% in Q4 2024, against a decline of 15.4% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $546.45 million (Q3 2025), $303.08 million (Q2 2025) and $328.61 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Dianthus Therapeutics 3.76 Bn 3.71 Bn - 493.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 493.40 Mn
Sep 30, 2025 546.45 Mn
Jun 30, 2025 303.08 Mn
Mar 31, 2025 328.61 Mn
Dec 31, 2024 352.48 Mn
Sep 30, 2024 337.90 Mn
Jun 30, 2024 358.22 Mn
Mar 31, 2024 372.69 Mn
Dec 31, 2023 168.87 Mn
Sep 30, 2023 178.38 Mn
Jun 30, 2023 -61.46 Mn
Mar 31, 2023 -50.82 Mn
Dec 31, 2022 -44.37 Mn
Sep 30, 2022 -34.75 Mn
Jun 30, 2022 -27.48 Mn
Mar 31, 2022 -22.07 Mn
Dec 31, 2021 -17.25 Mn
Sep 30, 2021 189.69 Mn
Jun 30, 2021 202.89 Mn
Mar 31, 2021 129.06 Mn
API Access

Dianthus Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=DNTH&period=max&api_key=YOUR_API_KEY